Gregory Chapron

Gregory Chapron has a diverse work experience starting in 1999. Gregory began their career as the Directeur de la Production at Come&Stay from December 1999 to August 2001. Gregory then joined Faust Pharmaceuticals, which later became Domain Therapeutics, as the CEO from September 2001 to May 2005, where they managed capital increases and led the development of Central Nervous System compounds. Gregory then returned to Come&Stay as the CFO from 2005 to 2009, overseeing major acquisitions and public offerings. From 2009 to 2011, Gregory worked as the Directeur at EneRis. Gregory then joined DOMAIN Therapeutics as the CFO from September 2011 to October 2014. Since November 2014, Gregory has held various roles at Splio, including CFO, COO, and currently, Co-CEO.

Gregory Chapron began their education at Ecole Sainte Genevieve in 1993 and completed their studies there in 1995. It is important to note that there is no mention of any degree obtained during this period. Following this, they attended Institut national agronomique Paris-Grignon from 1995 to 1998, earning a degree in "Diplôme d'Agronomie Générale" with a focus on engineering. Finally, from 1996 to 1999, they studied at HEC Paris, where they obtained a degree in HEC with a specialization in Finance, général.